View Item 

Show simple item record

An approach to identify, from DCE MRI, significant subvolumes of tumors related to outcomes in advanced head‐and‐neck cancera)
dc.contributor.authorWang, Peng
dc.contributor.authorPopovtzer, Aron
dc.contributor.authorEisbruch, Avraham
dc.contributor.authorCao, Yue
dc.date.accessioned2017-01-06T20:47:20Z
dc.date.available2017-01-06T20:47:20Z
dc.date.issued2012-08
dc.identifier.citationWang, Peng; Popovtzer, Aron; Eisbruch, Avraham; Cao, Yue (2012). "An approach to identify, from DCE MRI, significant subvolumes of tumors related to outcomes in advanced head‐and‐neck cancera)." Medical Physics 39(8): 5277-5285.
dc.identifier.issn0094-2405
dc.identifier.issn2473-4209
dc.identifier.urihttps://hdl.handle.net/2027.42/134885
dc.publisherWiley Periodicals, Inc.
dc.publisherAmerican Association of Physicists in Medicine
dc.subject.otherradiation therapy
dc.subject.otherhead‐and‐neck cancers
dc.subject.otherblood volume
dc.subject.otherDCE MRI
dc.subject.otherfunctional imaging biomarker
dc.subject.otherInvolving electronic [emr] or nuclear [nmr] magnetic resonance, e.g. magnetic resonance imaging
dc.subject.otherRadiation therapy
dc.subject.otherDigital computing or data processing equipment or methods, specially adapted for specific applications
dc.subject.otherCancer
dc.subject.otherMedical imaging
dc.subject.otherMagnetic resonance imaging
dc.subject.otherCluster analysis
dc.subject.otherPositron emission tomography
dc.subject.otherDosimetry
dc.subject.otherRadiation treatment
dc.subject.otherImage analysis
dc.subject.otherFailure analysis
dc.subject.otherData analysis
dc.subject.otherbiomedical MRI
dc.subject.otherMagnetic resonance imaging
dc.subject.otherFluid transport and rheology
dc.subject.otherHemodynamics
dc.subject.otherTreatment strategy
dc.subject.otherComputer‐aided diagnosis
dc.subject.othercancer
dc.subject.otherdosimetry
dc.subject.otherhaemodynamics
dc.subject.otherhaemorheology
dc.subject.othermedical computing
dc.titleAn approach to identify, from DCE MRI, significant subvolumes of tumors related to outcomes in advanced head‐and‐neck cancera)
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.contributor.affiliationumDepartment of Radiation Oncology and Department of Radiology, University of Michigan, Ann Arbor, Michigan 48103
dc.contributor.affiliationumDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan 48103
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/134885/1/mp7022.pdf
dc.identifier.doi10.1118/1.4737022
dc.identifier.sourceMedical Physics
dc.identifier.citedreferenceM. Nordsmark, S. M. Bentzen, V. Rudat, D. Brizel, E. Lartigau, P. Stadler, A. Becker, M. Adam, M. Molls, J. Dunst, D. J. Terris, and J. Overgaard, “ Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi‐center study,” Radiother. Oncol. 77, 18 – 24 ( 2005 ). 10.1016/j.radonc.2005.06.038
dc.identifier.citedreferenceP. J. Hoskin, M. I. Saunders, K. Goodchild, M. E. Powell, N. J. Taylor, and H. Baddeley, “ Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer,” Br. J. Radiol. 72, 1093 – 1098 ( 1999 ).
dc.identifier.citedreferenceE. Brun, E. Kjellen, J. Tennvall, T. Ohlsson, A. Sandell, R. Perfekt, R. Perfekt, J. Wennerberg, and S. E. Strand, “ FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma,” Head Neck 24, 127 – 135 ( 2002 ). 10.1002/hed.10037
dc.identifier.citedreferenceR. Hermans, M. Meijerink, W. Van den Bogaert, A. Rijnders, C. Weltens, and P. Lambin, “ Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head‐and‐neck cancer after radiotherapy,” Int. J. Radiat. Oncol. Biol. Phys. 57, 1351 – 1356 ( 2003 ). 10.1016/S0360‐3016(03)00764‐8
dc.identifier.citedreferenceK. Lehtio, O. Eskola, T. Viljanen, V. Oikonen, T. Gronroos, L. Sillanmaki, R. Grenman, and H. Minn, “ Imaging perfusion and hypoxia with PET to predict radiotherapy response in head‐and‐neck cancer,” Int. J. Radiat. Oncol. Biol. Phys. 59, 971 – 982 ( 2004 ). 10.1016/j.ijrobp.2003.12.014
dc.identifier.citedreferenceD. Thorwarth, S. M. Eschmann, J. Scheiderbauer, F. Paulsen, and M. Alber, “ Kinetic analysis of dynamic 18F‐fluoromisonidazole PET correlates with radiation treatment outcome in head‐and‐neck cancer,” BMC Cancer 5, 152 ( 2005 ). 10.1186/1471‐2407‐5‐152
dc.identifier.citedreferenceD. Gandhi, D. B. Chepeha, T. Miller, R. C. Carlos, C. R. Bradford, R. Karamchandani, F. Worden, A. Eisbruch, T. N. Teknos, G. T. Wolf, and S. K. Mukherji, “ Correlation between initial and early follow‐up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ‐preservation therapy,” AJNR Am. J. Neuroradiol. 27, 101 – 106 ( 2006 ).
dc.identifier.citedreferenceA. Zima, R. Carlos, D. Gandhi, I. Case, T. Teknos, and S. K. Mukherji, “ Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy?,” AJNR Am. J. Neuroradiol. 28, 328 – 334 ( 2007 ).
dc.identifier.citedreferenceY. Cao, A. Popovtzer, D. Li, D. B. Chepeha, J. S. Moyer, M. E. Prince, F. Worden, T. Teknos, C. Bradford, S. K. Mukherji, and A. Eisbruch, “ Early prediction of outcome in advanced head‐and‐neck cancer based on tumor blood volume alterations during therapy: A prospective study,” Int. J. Radiat. Oncol. Biol. Phys. 72, 1287 – 1290 ( 2008 ). 10.1016/j.ijrobp.2008.08.024
dc.identifier.citedreferenceA. Wismuller, A. Meyer‐Baese, O. Lange, M. F. Reiser, and G. Leinsinger, “ Cluster analysis of dynamic cerebral contrast‐enhanced perfusion MRI time‐series,” IEEE Trans. Med. Imaging 25, 62 – 73 ( 2006 ). 10.1109/TMI.2005.861002
dc.identifier.citedreferenceS. C. Chen and D. Q. Zhang, “ Robust image segmentation using FCM with spatial constraints based on new kernel‐induced distance measure,” IEEE Trans. Syst. Man Cybern., Part B: Cybern. 34, 1907 – 1916 ( 2004 ). 10.1109/TSMCB.2004.831165
dc.identifier.citedreferenceP. S. Tofts, G. Brix, D. L. Buckley, J. L. Evelhoch, E. Henderson, M. V. Knopp, H. B. Larsson, T. Y. Lee, N. A. Mayr, G. J. Parker, R. E. Port, J. Taylor, and R. M. Weisskoff, “ Estimating kinetic parameters from dynamic contrast‐enhanced T(1)‐weighted MRI of a diffusable tracer: Standardized quantities and symbols,” J. Magn. Reson. Imaging 10, 223 – 232 ( 1999 ). 10.1002/(SICI)1522‐2586(199909)10:3<223::AID‐JMRI2>3.0.CO;2‐S
dc.identifier.citedreferenceN. A. Mullani, R. A. Goldstein, K. L. Gould, S. K. Marani, D. J. Fisher, H. A. O’Brien Jr., and M. D. Loberg, “ Myocardial perfusion with rubidium‐82. I. Measurement of extraction fraction and flow with external detectors,” J. Nucl. Med. 24, 898 – 906 ( 1983 ).
dc.identifier.citedreferenceY. Cao and Z. Shen, “ Integrated software tools for multi‐modality functional images in cancer clinical trials,” Med. Phys. 34, 2395 – 2395 ( 2007 ). 10.1118/1.2760622
dc.identifier.citedreferenceC. Metz, ROCKIT, computer program, version 0.91b, Department of Radiology, The University of Chicago, Chicago, IL, 1998.
dc.identifier.citedreferenceJ. Asaumi, Y. Yanagi, H. Konouchi, M. Hisatomi, H. Matsuzaki, and K. Kishi, “ Application of dynamic contrast‐enhanced MRI to differentiate malignant lymphoma from squamous cell carcinoma in the head and neck,” Oral Oncol. 40, 579 – 584 ( 2004 ). 10.1016/j.oraloncology.2003.12.002
dc.identifier.citedreferenceS. Kim, H. Quon, L. A. Loevner, M. A. Rosen, L. Dougherty, A. M. Kilger, J. D. Glickson, and H. Poptani, “ Transcytolemmal water exchange in pharmacokinetic analysis of dynamic contrast‐enhanced MRI data in squamous cell carcinoma of the head and neck,” J. Magn. Reson. Imaging 26, 1607 – 1617 ( 2007 ). 10.1002/jmri.21207
dc.identifier.citedreferenceJ. G. Rajendran, D. A. Mankoff, F. O’Sullivan, L. M. Peterson, D. L. Schwartz, E. U. Conrad, A. M. Spence, M. Muzi, D. G. Farwell, and K. A. Krohn, “ Hypoxia and glucose metabolism in malignant tumors: Evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging,” Clin. Cancer Res. 10, 2245 – 2252 ( 2004 ). 10.1158/1078‐0432.CCR‐0688‐3
dc.identifier.citedreferenceJ. G. Rajendran, D. L. Schwartz, J. O’Sullivan, L. M. Peterson, P. Ng, J. Scharnhorst, J. R. Grierson, and K. A. Krohn, “ Tumor hypoxia imaging with [F‐18] fluoromisonidazole positron emission tomography in head and neck cancer,” Clin. Cancer Res. 12, 5435 – 5441 ( 2006 ). 10.1158/1078‐0432.CCR‐05‐1773
dc.identifier.citedreferenceD. Thorwarth, S. M. Eschmann, F. Paulsen, and M. Alber, “ A model of reoxygenation dynamics of head‐and‐neck tumors based on serial 18F‐fluoromisonidazole positron emission tomography investigations,” Int. J. Radiat. Oncol. Biol. Phys. 68, 515 – 521 ( 2007 ). 10.1016/j.ijrobp.2006.12.037
dc.identifier.citedreferenceN. Y. Lee, J. G. Mechalakos, S. Nehmeh, Z. Lin, O. D. Squire, S. Cai, K. Chan, P. B. Zanzonico, C. Greco, C. C. Ling, J. L. Humm, and H. Schoder, “ Fluorine‐18‐labeled fluoromisonidazole positron emission and computed tomography‐guided intensity‐modulated radiotherapy for head and neck cancer: A feasibility study,” Int. J. Radiat. Oncol. Biol. Phys. 70, 2 – 13 ( 2008 ). 10.1016/j.ijrobp.2007.06.039
dc.identifier.citedreferenceM. Nordsmark, M. Overgaard, and J. Overgaard, “ Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck,” Radiother. Oncol. 41, 31 – 39 ( 1996 ). 10.1016/S0167‐8140(96)91811‐3
dc.identifier.citedreferenceD. M. Brizel, G. S. Sibley, L. R. Prosnitz, R. L. Scher, and M. W. Dewhirst, “ Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck,” Int. J. Radiat. Oncol. Biol. Phys. 38, 285 – 289 ( 1997 ). 10.1016/S0360‐3016(97)00101‐6
dc.identifier.citedreferenceP. Stadler, A. Becker, H. J. Feldmann, G. Hansgen, J. Dunst, F. Wurschmidt, and M. Molls, “ Influence of the hypoxic subvolume on the survival of patients with head and neck cancer,” Int. J. Radiat. Oncol. Biol. Phys. 44, 749 – 754 ( 1999 ). 10.1016/S0360‐3016(99)00115‐7
dc.identifier.citedreferenceJ. A. Bertout, S. A. Patel, and M. C. Simon, “ The impact of O2 availability on human cancer,” Nat. Rev. Cancer 8, 967 – 975 ( 2008 ). 10.1038/nrc2540
dc.identifier.citedreferenceM. Bruehlmeier, B. Kaser‐Hotz, R. Achermann, C. R. Bley, M. Wergin, P. A. Schubiger, and S. M. Ametamey, “ Measurement of tumor hypoxia in spontaneous canine sarcomas,” Vet. Radiol. Ultrasound 46, 348 – 354 ( 2005 ). 10.1111/j.1740‐8261.2005.00065.x
dc.identifier.citedreferenceS. A. Nehmeh, N. Y. Lee, H. Schroder, O. Squire, P. B. Zanzonico, Y. E. Erdi, C. Greco, G. Mageras, H. S. Pham, S. M. Larson, C. C. Ling, and J. L. Humm, “ Reproducibility of intratumor distribution of (18)F‐fluoromisonidazole in head and neck cancer,” Int. J. Radiat. Oncol. Biol. Phys. 70, 235 – 242 ( 2008 ). 10.1016/j.ijrobp.2007.08.036
dc.identifier.citedreferenceH. Cho, E. Ackerstaff, S. Carlin, M. E. Lupu, Y. Wang, A. Rizwan, J. O’Donoghue, C. C. Ling, J. L. Humm, P. B. Zanzonico, and J. A. Koutcher, “ Noninvasive multimodality imaging of the tumor microenvironment: Registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia,” Neoplasia 11, 247 – 259 ( 2009 ). 10.1593/neo.81360
dc.identifier.citedreferenceJ. F. A. Jansen, H. Schöder, N. Y. Lee, Y. Wang, D. G. Pfister, M. G. Fury, H. E. Stambuk, J. L. Humm, J. A. Koutcher, and A. Shukla‐Dave, “ Noninvasive assessment of tumor microenvironment using dynamic contrast‐enhanced magnetic resonance imaging and 18F‐fluoromisonidazole positron emission tomography imaging in neck nodal metastases,” Int. J. Radiat. Oncol. Biol. Phys. ( 2009 ). 10.1016/j.ijrobp.2009.07.009
dc.identifier.citedreferenceS. C. Barranco, R. R. Perry, M. E. Durm, A. L. Werner, S. G. Gregorcyk, W. E. Bolton, P. Kolm, and C. M. Townsend Jr., “ Intratumor variability in prognostic indicators may be the cause of conflicting estimates of patient survival and response to therapy,” Cancer Res. 54, 5351 – 5356 ( 1994 ).
dc.identifier.citedreferenceY. Cao, V. Nagesh, D. Hamstra, C. I. Tsien, B. D. Ross, T. L. Chenevert, L. Junck, and T. S. Lawrence, “ The extent and severity of vascular leakage as evidence of tumor aggressiveness in high‐grade gliomas,” Cancer Res. 66, 8912 – 8917 ( 2006 ). 10.1158/0008‐5472.CAN‐05‐4328
dc.identifier.citedreferenceY. Cao, C. I. Tsien, V. Nagesh, L. Junck, R. Ten Haken, B. D. Ross, T. L. Chenevert, and T. S. Lawrence, “ Clinical investigation survival prediction in high‐grade gliomas by MRI perfusion before and during early stage of RT,” Int. J. Radiat. Oncol. Biol. Phys. 64, 876 ( 2006 ). 10.1016/j.ijrobp.2005.09.001
dc.identifier.citedreferenceE. D. Angelini, J. Atif, J. Delon, E. Mandonnet, H. Duffau, and L. Capelle, “ Detection of glioma evolution on longitudinal MRI studies,” in Proceedings of the 4th IEEE International Symposium on Biomedical Imaging: From Nano to Macro, 2007, Arlington, VA (unpublished).
dc.identifier.citedreferenceO. I. Craciunescu, D. S. Yoo, E. Cleland, N. Muradyan, M. D. Carroll, J. R. MacFall, D. P. Barboriak, and D. M. Brizel, “ Dynamic contrast‐enhanced MRI in head‐and‐neck cancer: The impact of region of interest selection on the intra‐ and interpatient variability of pharmacokinetic parameters,” Int. J. Radiat. Oncol. Biol. Phys. 82, e345 – e350 ( 2012 ). 10.1016/j.ijrobp.2011.05.059
dc.identifier.citedreferenceB. A. Moffat, T. L. Chenevert, T. S. Lawrence, C. R. Meyer, T. D. Johnson, Q. Dong, C. Tsien, S. Mukherji, D. J. Quint, S. S. Gebarski, P. L. Robertson, L. R. Junck, A. Rehemtulla, and B. D. Ross, “ Functional diffusion map: A noninvasive MR1 biomarker for early stratification of clinical brain tumor response,” Proc. Natl. Acad. Sci. U.S.A. 102, 5524 – 5529 ( 2005 ). 10.1073/pnas.0501532102
dc.identifier.citedreferenceI. J. Simpson, M. W. Woolrich, A. R. Groves, and J. A. Schnabel, “ Longitudinal brain MRI analysis with uncertain registration,” Med. Image Comput. Comput. Assist. Interv. 14, 647 – 654 ( 2011 ).
dc.identifier.citedreferenceG. Chetelat, B. Landeau, F. Eustache, F. Mezenge, F. Viader, V. de la Sayette, B. Desgranges, and J. C. Baron, “ Using voxel‐based morphometry to map the structural changes associated with rapid conversion in MCI: A longitudinal MRI study,” Neuroimage 27, 934 – 946 ( 2005 ). 10.1016/j.neuroimage.2005.05.015
dc.identifier.citedreferenceI. Yanovsky, P. M. Thompson, S. J. Osher, H. Xue, D. W. Shattuck, A. W. Toga, and A. D. Leow, “ Validating unbiased registration on longitudinal MRI scans from the Alzheimer’s disease neuroimaging initiative (ADNI),” in Proceedings of the 5th IEEE International Symposium on Biomedical Imaging: From Nano to Macro, 2008, Paris, France (unpublished).
dc.identifier.citedreferenceY. Cao, D. Li, Z. Shen, and D. Normolle, “ Sensitivity of quantitative metrics derived from DCE MRI and a pharmacokinetic model to image quality and acquisition parameters,” Acad. Radiol. 17, 468 – 478 ( 2010 ). 10.1016/j.acra.2009.10.021
dc.identifier.citedreferenceM. Mancas and B. Gosselin, “ Towards an automatic tumor segmentation using iterative watersheds,” Proc. SPIE 5370, 1598 – 1608 ( 2004 ).
dc.identifier.citedreferenceP. Tylsky, G. Bonniaud, E. Decencière, J. Stawiaski, D. Lefkopoulos, and M. Ricard, “ 18F‐FDG PET images segmentation using morphological watershed: A phantom study,” in Proceedings of IEEE Nuclear Science Symposium and Medical Imaging Conference, San Diego, CA, 2006.
dc.identifier.citedreferenceX. Geets, J. A. Lee, A. Bol, M. Lonneux, and V. Gregoire, “ A gradient‐based method for segmenting FDG‐PET images: Methodology and validation,” Eur. J. Nucl. Med. Mol. Imaging 34, 1427 – 1438 ( 2007 ). 10.1007/s00259‐006‐0363‐4
dc.identifier.citedreferenceM. Wanet, J. A. Lee, B. Weynand, M. De Bast, A. Poncelet, V. Lacroix, E. Coche, V. Gregoire, and X. Geets, “ Gradient‐based delineation of the primary GTV on FDG‐PET in non‐small cell lung cancer: A comparison with threshold‐based approaches, CT and surgical specimens,” Radiother. Oncol. 98, 117 – 125 ( 2010 ). 10.1016/j.radonc.2010.10.006
dc.identifier.citedreferenceM. Hatt, F. Lamare, N. Boussion, A. Turzo, C. Collet, F. Salzenstein, C. Roux, P. Jarritt, K. Carson, C. Cheze‐Le Rest, and D. Visvikis, “ Fuzzy hidden Markov chains segmentation for volume determination and quantitation in PET,” Phys. Med. Biol. 52, 3467 – 3491 ( 2007 ). 10.1088/0031‐9155/52/12/010
dc.identifier.citedreferenceM. Hatt, C. Cheze le Rest, A. Turzo, C. Roux, and D. Visvikis, “ A fuzzy locally adaptive Bayesian segmentation approach for volume determination in PET,” IEEE Trans. Med. Imaging 28, 881 – 893 ( 2009 ). 10.1109/TMI.2008.2012036
dc.identifier.citedreferenceM. Hatt, C. Cheze le Rest, P. Descourt, A. Dekker, D. De Ruysscher, M. Oellers, P. Lambin, O. Pradier, and D. Visvikis, “ Accurate automatic delineation of heterogeneous functional volumes in positron emission tomography for oncology applications,” Int. J. Radiat. Oncol. Biol. Phys. 77, 301 – 308 ( 2010 ). 10.1016/j.ijrobp.2009.08.018
dc.identifier.citedreferenceD. J. Lee et al., “ Results of an RTOG phase III trial (RTOG 85‐27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas,” Int. J. Radiat. Oncol. Biol. Phys. 32, 567 – 576 ( 1995 ). 10.1016/0360‐3016(95)00150‐W
dc.identifier.citedreferenceR. J. Bensadoun, M. C. Etienne, O. Dassonville, P. Chauvel, X. Pivot, P. Y. Marcy, B. Prevost, B. Coche‐Dequeant, S. Bourdin, J. Vallicioni, G. Poissonnet, A. Courdi, E. Teissier, J. L. Lagrange, A. Thyss, J. Santini, F. Demard, M. Schneider, and G. Milano, “ Concomitant b.i.d. radiotherapy and chemotherapy with cisplatin and 5‐fluorouracil in unresectable squamous‐cell carcinoma of the pharynx: Clinical and pharmacological data of a French multicenter phase II study,” Int. J. Radiat. Oncol. Biol. Phys. 42, 237 – 245 ( 1998 ). 10.1016/S0360‐3016(98)00235‐1
dc.identifier.citedreferenceJ. Bernier, H. D. Thames, C. D. Smith, and J. C. Horiot, “ Tumor response, mucosal reactions and late effects after conventional and hyperfractionated radiotherapy,” Radiother. Oncol. 47, 137 – 143 ( 1998 ). 10.1016/S0167‐8140(97)00221‐1
dc.identifier.citedreferenceF. Denis, P. Garaud, E. Bardet, M. Alfonsi, C. Sire, T. Germain, P. Bergerot, B. Rhein, J. Tortochaux, P. Oudinot, and G. Calais, “ Late toxicity results of the GORTEC 94‐01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced‐stage oropharynx carcinoma: Comparison of LENT/SOMA, RTOG/EORTC, and NCI‐CTC scoring systems,” Int. J. Radiat. Oncol. Biol. Phys. 55, 93 – 98 ( 2003 ). 10.1016/S0360‐3016(02)03819‐1
dc.identifier.citedreferenceC. J. Langer, J. Harris, E. M. Horwitz, N. Nicolaou, M. Kies, W. Curran, S. Wong, and K. Ang, “ Phase II study of low‐dose paclitaxel and cisplatin in combination with split‐course concomitant twice‐daily reirradiation in recurrent squamous cell carcinoma of the head and neck: Results of Radiation Therapy Oncology Group Protocol 9911,” J. Clin. Oncol. 25, 4800 – 4805 ( 2007 ). 10.1200/JCO.2006.07.9194
dc.identifier.citedreferenceD. I. Rosenthal, J. S. Lewin, and A. Eisbruch, “ Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer,” J. Clin. Oncol. 24, 2636 – 2643 ( 2006 ). 10.1200/JCO.2006.06.0079
dc.identifier.citedreferenceC. Fakhry, W. H. Westra, S. Li, A. Cmelak, J. A. Ridge, H. Pinto, A. Forastiere, and M. L. Gillison, “ Improved survival of patients with human papillomavirus‐positive head and neck squamous cell carcinoma in a prospective clinical trial,” J. Natl. Cancer. Inst. 100, 261 – 269 ( 2008 ). 10.1093/jnci/djn011
dc.identifier.citedreferenceF. P. Worden, B. Kumar, J. S. Lee, G. T. Wolf, K. G. Cordell, J. M. Taylor, S. G. Urba, A. Eisbruch, T. N. Teknos, D. B. Chepeha, M. E. Prince, C. I. Tsien, N. J. D’Silva, K. Yang, D. M. Kurnit, H. L. Mason, T. H. Miller, N. E. Wallace, C. R. Bradford, and T. E. Carey, “ Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: Response and survival positively associated with HPV16 copy number,” J. Clin. Oncol. 26, 3138 – 3146 ( 2008 ). 10.1200/JCO.2007.12.7597
dc.identifier.citedreferenceR. Hermans, P. Lambin, W. Van den Bogaert, K. Haustermans, A. Van der Goten, and A. L. Baert, “ Non‐invasive tumour perfusion measurement by dynamic CT: Preliminary results,” Radiother. Oncol. 44, 159 – 162 ( 1997 ). 10.1016/S0167‐8140(97)01913‐0
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
mp7022.pdf
Size:
695.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.